A study indicated that TGR5 activation inhibited kidney disease in obesity and diabetes by inhibiting oxidative stress via promoting sirtuin 1 (SIRT1) and sirtuin 3 (SIRT3) expression12. This evidence concerns the gene SIRT3 and diabetes mellitus.